Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Philip

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Cancer & Clinical Oncology|November 1, 1987
Acetylator status and its relationship to breast cancer and other diseases of the breastP A Philip, H J Rogers, R R Millis, et al.
British Journal of Cancer|April 1, 1993
The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivoP A Philip, L Kaklamanis, J Carmichael, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Use of V79 cells with stably transfected cytochrome P450 cDNAs in studying the metabolism and effects of cytotoxic drugsP A Philip, S Ali-Sadat, J Doehmer, et al.
British Journal of Cancer|February 1, 1993
Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisoneP A Philip, J Carmichael, K Tonkin, et al.
Anti-Cancer Drugs|October 11, 2001
Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft modelR M Mohammad, N V Adsay, P A Philip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancerJ A Zonder, A F Shields, M Zalupski, et al.
Investigational New Drugs|September 18, 1998
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinomaM M Zalupski, A F Shields, P A Philip, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinomaP A Philip, G J Rustin, J A Ledermann, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignanciesU N Vaishampayan, E Ben-Josef, P A Philip, et al.
British Journal of Cancer|December 1, 1988
Bone disease in testicular and extragonadal germ cell tumoursR N Hitchins, P A Philip, B Wignall, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Cancer & Clinical Oncology|November 1, 1987
Acetylator status and its relationship to breast cancer and other diseases of the breastP A Philip, H J Rogers, R R Millis, et al.
British Journal of Cancer|April 1, 1993
The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivoP A Philip, L Kaklamanis, J Carmichael, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Use of V79 cells with stably transfected cytochrome P450 cDNAs in studying the metabolism and effects of cytotoxic drugsP A Philip, S Ali-Sadat, J Doehmer, et al.
British Journal of Cancer|February 1, 1993
Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisoneP A Philip, J Carmichael, K Tonkin, et al.
Anti-Cancer Drugs|October 11, 2001
Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft modelR M Mohammad, N V Adsay, P A Philip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancerJ A Zonder, A F Shields, M Zalupski, et al.
Investigational New Drugs|September 18, 1998
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinomaM M Zalupski, A F Shields, P A Philip, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinomaP A Philip, G J Rustin, J A Ledermann, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignanciesU N Vaishampayan, E Ben-Josef, P A Philip, et al.
British Journal of Cancer|December 1, 1988
Bone disease in testicular and extragonadal germ cell tumoursR N Hitchins, P A Philip, B Wignall, et al.
Pageof 7